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K -INDUCED DILATION OF CREMASTERIC ARTERIOLES INVOLVES NA /K
+
ATPASE AND INWARD RECTIFIER K CHANNELS
Wendy Burns, Ph.D.
Western Michigan University, 2003
The purpose of this study was to evaluate the possible mechanisms involved in
cremasteric arteriolar dilation as a result of increased concentrations of ([K+]o)
extracellular potassium. Many other studies suggested that Na+/K+ ATPase or KIR

channels are responsible for potassium-induced vasodilation in other systems (2, 12, 22,
40, 46, 52, 16, 17, 25, 33, 34, 85, 99, 151). However, these studies show only partial
inhibition of dilation as a result of independent blockage of each mechanism. The
hypothesis of this study was that both mechanisms contribute to potassium-induced
dilation seen in cremasteric arterioles.
First or second order arterioles were isolated (n=81), cannulated and pressurized
with physiological salt solution (PSS) to 70 cm H20 at 34° C with no flow through their
lumens. The vessels developed spontaneous tone in PSS containing 5 mM K+. Elevation
of [K+]o from 5 mM to 8.75, 12.5 or 20 mM was studied to determine if K+ caused
concentration-dependent dilation. Arteriolar diameter was measured using a computerbased diameter tracking system. To elucidate the mechanism(s) responsible for the
dilation, vessels were exposed to known blockers of KIR and Na+/K+ ATPase. Barium (50

µM or 100 µM), which blocks KIR channels, was applied to vessels do determine if
blockage of KIR channels would inhibit potassium-induced vasodilation. Ouabain (0.1
mM or 1.0 mM), an inhibitor of the Na+/K+ ATPase, was applied to vessels in order to
determine if blockage of Na+/K+ ATPase would result in inhibition of potassium-induced
vasodilation.
Increased [K+]o caused transient vasodilation. The arterioles dilated and then
returned to, or below baseline despite the maintenance of the elevated [K+]o.
Concentrations of barium (50 µM and 100 µM) (n=8 for both concentrations p< 0.05)
resulted in a reduction in the peak dilation to 20 mM K+. Ouabain, 0.1 mM (n=9, p<0.05)
or 1 mM (n=14, p<0.05), resulted in a reduction in the peak dilation to 20 mM K+.
However, the dilation was not consistently eliminated by either blocker. A combination
of barium (100 µM) and ouabain (1 mM) was required to dependably abolish K+-induced
arteriolar dilation.
The effects of both barium and ouabain appeared to be specific because dilation
induced by acetylcholine was not inhibited by either agent.
These results suggest that skeletal muscle arterioles are intrinsically sensitive to
changes in [K+]o, and that the transient nature of the response to elevated [K+]o is an
innate property of the arteriolar muscle cells. Increases in [K+]o appear to dilate skeletal
muscle arterioles by a mechanism that involves both KIR channels and the Na+/K+
ATPase.
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CHAPTER 1
INTRODUCTION
Background and Purpose of the Study
Skeletal muscle represents 40% of body mass and contributes substantially
in the regulation of blood pressure and flow, whole body metabolism, and
cardiovascular homeostasis, in addition to its vital role in locomotion and other
contraction-related functions (13, 47, 50, 95, 122, 146).
Skeletal muscle contraction leads to large increases in blood flow to the active
muscle through dilation of resistance arteries and arterioles (27, 95, 126, 127, 133, 141).
However, the mechanisms underlying this active or functional hyperemia remain poorly
understood. The release of potassium ions from active skeletal muscle has been
implicated in functional hyperemia for nearly 40 years. Numerous studies have shown
that elevated extra-cellular concentration of K+ ([K+]o) can cause vasodilatation, and that
the K+ released from skeletal muscle fibers during the re-polarization phase of muscle
action potentials can accumulate in the interstitial space at concentrations sufficient to
cause vasodilatation (68, 88, 122, 151). However, the cellular mechanisms by which the
vascular smooth muscle cells in the walls of skeletal muscle arterioles relax to cause
vasodilatation in response to elevated [K+]o remains unclear. Early studies suggested that
elevated [K+]o caused vasodilatation by activation of the electrogenic Na+/K+ ATPase and
transient membrane hyperpolarization (25). Recent in vivo studies of rat skeletal muscle
1

microcirculation support this hypothesis (99). However, other recent in vitro studies,
performed in small cerebral and coronary arteries, suggest that in those vascular beds,
elevated [K+]o causes membrane hyper-polarization and relaxation of vascular smooth
muscle cells by activating inward rectifying K+ (KIR) channels (16, 18, 33). The purpose
of the present study was to: 1.) determine the effects of elevated [K+]o on the diameter of
cannulated arterioles isolated from hamster cremaster muscles as an in vitro model
system to study the mechanism of action of elevated [K+]o on skeletal muscle arterioles
and 2.) evaluate the roles played by the Na+/K+ ATPase and KIR channels in dilation of
skeletal muscle arterioles in response to elevated [K+]o. This second aim was
accomplished by assessing the effects of Ba2+, an inhibitor of KIR channels, and ouabain,
an inhibitor of Na+/K+ ATPase , on dilation of skeletal muscle arterioles induced by
elevated [K+]o.

Regulation of Skeletal Muscle Blood Flow
Proper function of skeletal muscle requires continuous, regulated blood
flow to deliver oxygen, hormones, and nutrients to the tissue and for removal of
CO2 and other wastes produced during muscle contraction (13, 47, 50, 95, 122).
Arterioles in the microcirculation of skeletal muscle play an important role in
regulating muscle blood flow, as they are major sites of blood flow regulation
within and to skeletal muscle (95, 96). Skeletal muscle arterioles also importantly
determine total systemic vascular resistance and hence blood pressure regulation
and cardiovascular homeostasis (13, 47, 50, 95, 122).
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Regulation of blood flow and pressure is accomplished by changes in the diameter
of arterioles resulting from contraction or relaxation of vascular smooth muscle cells in
their walls (13, 57, 82). Under resting conditions, skeletal muscle arterioles have
substantial tone (13, 57, 82). That is, the vascular smooth muscle in the wall of these
microvessels is active and in a state of partial contraction resisting the distending force of
the blood pressure in the vessel lumen. Increases in tone lead to decreases in diameter
(vasoconstriction) and decreases in tone lead to increases in diameter (vasodilatation) (13,
57, 58, 82, 76).

Factors Influencing Arteriolar Tone
Arteriolar tone in vivo is a complex, dynamic variable that is determined by both
vasoconstrictor and vasodilator influences on vascular smooth muscle cells. The primary
vasoconstrictor influences that contribute to skeletal muscle arteriolar tone are the
myogenic response of the smooth muscle cells to the blood pressure (myogenic tone),
sympathetic nerve activity, circulating hormones (angiotensin II, vasopressin and
epinephrine) and endothelin released from the vascular endothelium (23, 42). Vasodilator
influences include endothelium-derived vasodilators such as nitric oxide (NO),
prostacyclin (PGI2) and endothelium-derived hyperpolarizing factor (EDHF); vasodilator
substances released from skeletal muscle cells such as adenosine, CO2, H+ and K+;
reduced PO2 and elevated interstitial osmolarity resulting from skeletal muscle
metabolism; and substances released from sensory nerves such as substance P and
calcitonin gene-related peptide (7, 14, 17, 29, 121). In vivo, all of these factors act on the
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vascular smooth muscle cells in the wall of arterioles to determine arteriolar tone and
blood flow.
The factors outlined above modulate arteriolar tone, by altering intracellular Ca2+
concentration [Ca2+]I and/or the Ca2+-sensitivity of the contractile machinery (85, 140).
Like all muscle, vascular smooth muscle contraction is triggered by an increase in
[Ca2+]I. Calcium binds to the regulatory protein, calmodulin, and the Ca2+-calmodulin
complex then activates myosin-light-chain kinase (MLCK). This kinase phosphorylates
the 20kD myosin regulatory light chains, a process that then allows myosin to interact
with actin in the crossbridge cycle resulting in force production and/or muscle cell
shortening (140). The myosin light chains are dephosphorylated by myosin-light-chain
phosphatase (MLCP) terminating the contraction sequence. The level of activation (i.e.,
tone) of the smooth muscle is determined, to a large extent, by the degree of
phosphorylation of the myosin light chains which is determined by the ratio of activity of
MLCK and MLCP: tone can be modulated by changes in the activity of either enzyme.
As noted above, the intracellular concentration of Ca2+ determines the activity of the
MLCK (140). The activity of MLCP, and hence the Ca2+ sensitivity of the system, can
also be modulated. Vasoconstrictors that act through G-protein-coupled receptors such as
norepinephrine, angiotensin II, and vasopressin tend to lead to inhibition of the MLCP
and hence an increase in Ca2+ sensitivity (140). In contrast, vasodilators such as NO and
PGI2 that act through the cGMP and cAMP second messenger pathways appear to
increase the activity of the MLCP and decrease the Ca2+ sensitivity of the contractile
machinery (29, 42, 140).
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Intracellular Ca2+ concentration in vascular smooth muscle depends on the influx
of Ca2+ through sarcolemmal ion channels, release of Ca2+ from intracellular stores and
the activity of various pumps and exchangers that remove Ca2+ from the cytosol (20, 23,
76, 78, 82). In the microcirculation, Ca2+ influx through voltage-gated Ca2+ channels
appears to play a major role as a source of activator Ca2+ used by the vascular smooth
muscle (78). Thus, the membrane potential of vascular smooth muscle cells, by
controlling the open-state probability of voltage-gated Ca2+ channels, importantly affects
vascular smooth muscle tone (78, 82). Many of the factors listed above that modulate
arteriolar tone do so by influencing the membrane potential of vascular smooth muscle
cells with depolarization leading to vasoconstriction (increased tone) and
hyperpolarization leading to vasodilatation (decreased tone) (4). As will be discussed
below, elevated [K+]o appears to cause dilation by hyperpolarizing the membrane of
vascular smooth muscle cells leading to closure of voltage-gated Ca2+ channels, a
reduction in intracellular Ca2+, and decreased tone.

Membrane Potential and K + Channels
Membrane potential of vascular smooth muscle is determined by concentration
gradients of ions across the plasma membrane, the permeability of the membrane to these
ions (determined by the open state probability and the number of ion channels present),
and the activity of ion pumps and exchangers moving these charged molecules across the
membrane (78). In the steady state, with a constant membrane potential, the movement of
charge across the membrane is balanced. That is, the net movement of charge into the cell
is exactly balanced by the net movement out so that the cell is in a dynamic equilibrium
5

(48, 49, 76, 78). Disruption of this balance by altering the influx or efflux of any ionic
component will result in a change in membrane potential, and a subsequent change in
smooth muscle tone.
In smooth muscle, as in most cells, K+ ions play a dominant role in determining
resting membrane potential because of the large number of K+ channels expressed and
their activity (18, 30). Opening of additional K+ channels allows K+ ions to diffuse out of
the cells, down their electrochemical gradient. This loss of positive charge from the cells
hyperpolarizes the membrane from its resting potential of –30 to –40 mV (in arteriolar
smooth muscles) and moves the membrane potential closer to the K+ equilibrium
potential (-83 mV). Similarly, closure of K+ channels leads to membrane depolarization.
There are at least four different types of potassium channels that contribute
to the regulation of membrane potential in vascular smooth muscle cells: 1) ATPsensitive K+ (KATP ) channels, 2) Calcium-activated K+ (K Ca ) channels, 3) Voltage
gated K + (K V) channels and 4) Inward rectifier K+ (KIR ) channels (18, 76, 77, 80 ).
Of these, KIR channels have been implicated in K +-induced vasodilation (18, 33,
34). Therefore, the remainder of the discussion of K+ channels and regulation of
membrane potential and arteriolar tone will focus on these channels.

Inward Rectifier K + Channels in Vascular Smooth Muscle
Inward rectifier potassium channels were first found in skeletal muscle by Katz
(85). These channels were first proposed to be in vascular smooth muscle by Edwards
and Hirst (33, 34). Rectification refers to a change in channel conductance with voltage
such that ions pass more easily through the channel in one direction than in the other
6

direction. (18, 33, 34, 118) Inward rectification means that at a given electrochemical
gradient (driving force), the inward flow of K+ ions is greater than the outward flow for
the opposite driving force. (33, 34) The mechanism of inward rectification in KIR
channels involves voltage dependent block of the channel pore by cytoplasmic
magnesium and polyamines (16, 33, 34, 125). Inward rectifier potassium channels mainly
conduct inward current below the equilibrium potential for K+ and do not allow much
outward flow of current (33, 34, 156).

Structure
Inward rectifier potassium (KIR) channels that are expressed in blood
vessels are from a gene family called Kir, specifically Kir 2.X (2, 16, 80, 84, 91,
97, 118-120, 157). The channels in this family are considered strong rectifiers (see
below). These channels are tetramers made of proteins that are approximately 370500 amino acids in length, and have a molecular mass of approximately 40 KDa
(120). KIR channels have two transmembrane domains (M1 and M2) and between
them is an H5 or P region, which dips into the membrane from the outside, and is
considered to form the ion conductive pore (120, 123). (Figure) 1. A functional KIR
channel is composed of four of these subunits. The amino (N) and carboxy (C)
terminals are both located within the cytoplasm. The N and C terminals are
variable, but the central portion is more conserved allowing for subtypes of KIR
channels (120). Subtypes include weak (Kir 1.1 and 6.1 and 6.2 subfamilies) and
strong inward rectifiers (Kir 2.1-2.3, 3.1-3.5 and 4.1) (120). Weak inward
rectifiers are those whose rectification is attributed to block by internal divalent
7

2+

metal cations, such as Mg . Strong inward rectifiers have an additional intrinsic
gating mechanism that can be attributed to cytoplasmic polyamines. (66, 112) The
Kir 2.X family of channels are considered to be “classical” strong inward rectifiers
(120).
Distribution
Genes encoding different subtypes of inward rectifying potassium channels have
been found in several species and organ systems. Those similar to channels thought to be
activated in this study, Kir 2.X, have been observed in skeletal muscle, heart, brain,
bronchial smooth muscle, and vascular smooth muscle (66, 120). The distribution of KIR
channels varies from cell to cell, even within a particular tissue (118, 120). In vascular
smooth muscle the classical Kir 2.1, strong rectifiers, as well as some weak rectifiers
from the Kir 6.1 and 6.2 subfamilies (more closely associated with KATP channels) (66,
120) are found. The strong rectifiers (Kir 2.1) are those believed to be involved in
potassium-induced arteriolar dilation (66, 120). Studies have suggested that within the
vasculature, the density of KIR channels is greater in vessels with smaller diameters, such
as resistance-sized arteries and arterioles (118). KIR channels have been estimated to have
a density of approximately 100-500 per smooth muscle cell (120). Open potassium
channels do not have to be great in number in order to significantly contribute to
membrane potential and tone (66).
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Fig. 1 – Schematic of Molecular Structure.

Figure 1 illustrates the typical molecular structure of inward rectifier
channels. Arrow A represents the M1 trans-membrane domain. Arrow B represents
the H5 or P pore region, which is within the membrane. Arrow C represents the
M2 trans-membrane domain. Arrow D represents the C-terminus. Arrow E
represents the N terminus. An entire functional channel is composed of four
peptide protein subunits.

9

current

voltage
EK

Fig 2 - Current-Voltage Relationship for KIR Channels.

Figure 2 shows a theoretical I-V plot for KIR channels showing the inward
rectification at potentials positive to the K+ equilibrium potential (EK), and the outward
“hump” just positive to EK. By convention, negative current reflects positive charge
moving into cells (inward current) and positive current reflects positive charge moving
out of cells (outward current). See text for more information.
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Function
In cells such as cardiac muscle, skeletal muscle, and neurons, KIR channels
primarily function to stabilize the resting membrane potential of these cells at, or very
near, the K+ equilibrium potential (EK = -83 mV) (120). The current-voltage relationship
of these channels shows strong inward rectification at potentials positive to the EK
(Figure 2). That is, these channels conduct K+ ions into the cells much more easily than
out of the cells. At membrane potentials slightly more positive (5-15 mV) than EK, there
is an outward “hump” in the I-V relationship such that in this region the channels can
conduct K+ ions out of cells. At potentials >15 mV positive to EK these channels are
relatively impermeable to K+. This “N” shaped I-V relationship provides the stabilization
function noted above. Any process (unrelated to KIR channels) that would tend to
hyperpolarize cells beyond EK would lead to inward current flow through KIR channels,
which would return the membrane potential towards EK. Similarly, anything that would
tend to depolarize the cells and push membrane potential more positive than EK would
result in outward current flow through KIR channels which would counteract the
depolarizing stimulus and return the membrane potential towards EK.
KIR channels may act as sensors for small changes in [K+]o (76, 77, 118, 120).
Elevated [K+]o increases the conductance of these channels to K+ ions, and shifts EK
toward more positive potentials. As can be seen in Figure 3, this shifts the outward
“hump” of the KIR I-V relationship such that outward K+ ion current can flow through the
channels at more positive potentials. This outward current would tend to hyperpolarize
the cells and push the membrane potential towards the new EK .
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5 mM K+
current

15
5 mM K+
EK in 5 mM K+

voltage

resting
membrane
potential

Fig. 3- Effects of Increased [K+]o on KIR Channel I-V Relationship.

Figure 3 shows theoretical I-V relationships for KIR channels in normal (5 mM)
and elevated (15 mM) [K+]o . Elevated [K+]o increases the conductance of the KIR
channels as noted by the increase in the slope of the inward portion of the I-V curve in 15
mM K+. In addition, EK, the reversal potential in the I-V plot, shifts to more positive
values. This allows K+ ions to flow out of the cell at resting membrane potential. See text
for more information.
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Studies in submucosal arterioles and in cerebral arterioles and small arteries have
clearly demonstrated K+ currents that display inward rectification that varies with the
[K+]o (33-35, 84, 91, 97, 118, 119). Others have shown that outward current at –50 mV
can be inhibited by 100 µM Ba2+ in smooth muscle cells isolated from coronary arteries
of the rat (123, 125). These data are consistent with the idea that vascular KIR channels
can conduct K+ in the outward direction and potentially could be involved in dilation
induced by elevated K+.

Pharmacology
Barium ions block KIR channels at concentrations lower than 100 µM.
Concentrations of Ba2+ greater than 100 µM also block KATP (76, 112, 120). Inhibition of
currents through KIR channels by Ba2+ is greater at more negative membrane potentials
(76, 112). Cesium (Cs+) 100 µM, has also been shown to block KIR channels in a variety
of tissues (104, 119, 125). Barium block of KIR channels is voltage dependent and affects
currents through the channel(120, 125). Barium block occurs when the molecule attaches
to the P loop, which is the K+ selectivity filter (118, 119). Barium block is reversible
when the molecule is removed. Currents through KIR channels have also been reduced by
elevation of external calcium and magnesium concentrations, up to 10 mM. This type of
inhibition has been shown to occur at low-affinity block sites, is superficial and lacks
voltage dependence. (16, 33, 34)
Other potassium channel blockers such as glibenclamide (KATP channel blocker),
low concentrations of TEA+ (KCa channel blocker) and charybdotoxin (KCa channel
blocker) have had little effect on KIR channel currents (21, 76, 77, 101). Alterations in the
13

extra-cellular pH have been shown to have little effect on the inward currents through KIR
channels (118, 119).

+

+

Na /K ATPase in Vascular Smooth Muscle
In addition to ion channels, membrane potential of vascular smooth muscle cells
can be influenced by other processes that move ions across the cell membrane such as
exchangers and pumps. In particular, the Na+/K+ ATPase has received considerable
attention as a potential mechanism by which elevated [K+]o might cause membrane
hyperpolarization and vasodilation.
The Na+/K+ ATPase is a transmembrane enzyme complex that couples ATP
hydrolysis with the transport of sodium and potassium against their electrochemical
gradients (9, 65). Dean (1941) was the first to propose the existence of this enzyme. The
Na+/K+ ATPase has been found in nearly all mammalian cells (9 ). The Na+/K+ ATPase
was first shown to be in vascular tissues by Bonting (1961). There have been numerous
studies of this enzyme in many cell types including vascular smooth muscle (21). This
section of the paper will discuss the structure, distribution and function of the Na+/K+
ATPase within vascular smooth muscle.

Structure
The Na+/K+ ATPase is a heterodimer consisting of two subunits, an alpha (α)
subunit and a beta (β) subunit. The alpha subunit is known to have three possible
isoforms and the beta subunit is known to have two possible isoforms (9, 12, 40, 65,
100). The alpha subunit has cytoplasmic N and C terminals, with a span of ten
14

transmembrane domains (9, 12, 100). This subunit has a molecular weight of
approximately 100,000 KDa. The alpha subunit contains the ATP binding site as well as
the cardiac glycoside (Na+/K+ ATPase blocker) binding site (9, 12, 46, 100). The beta
subunit has a cytoplasmic N terminus and a C terminus that lies on the outside of the cell,
with only one transmembrane domain. The beta subunit is glycosylated and can range is
molecular weight from 35,000 to 65,000 (when fully glycosylated) (9, 12. 46, 100). The
specific function of this subunit has yet to be clearly elucidated. The α and β isoforms are
thought to be tissue specific (12, 65, 100). Figure 4 illustrates this ATPase.

Distribution
The Na+/K+ ATPase has been shown to be expressed in many species and in many
tissues. The sodium-potassium ATPases are a part of the large family known as PATPases, along with Ca-ATPase, H-ATPases (seen in lower organisms) and hydrogenpotassium ATPase (seen along with sodium-potassium ATPases in higher eukaryotes).
(12) In mammals, the α and β isoforms are expressed and are distributed in a tissue
specific manner (40, 46). This enzyme is known to be present in large amounts in the
heart, kidney, brain and skeletal muscle (12, 40, 46). The Na+/K+ ATPase is also
expressed in the vascular system (52, 55). The α1β1 form is ubiquitous, and is seen in
vascular smooth muscle along with a truncated α1 subunit (12, 46). However, the
electrogenic contribution of this ATPase differs in smooth muscle cells of different
vascular beds (12, 52).

15

Fig. 4- Typical Molecular Structure of the Na+/K+ ATPase.

The Na+/K+ ATPase has alpha and beta subunits. The A arrow represents the
transmembrane domains, the alpha subunit having ten and the beta subunit having one.
Arrow B represents the N terminus of the alpha subunit. Arrow C represents the C
terminus of the alpha subunit. Arrow E represents the C-terminus of the beta subunit.
Arrow D represents the N terminus of the beta subunit.

16

Function
The Na+/K+ ATP pump moves three Na+ ions out of the cell for each two K+ ion
moved into the cell per ATP hydrolyzed. The activity of the Na+/K+ ATPase is stimulated
by elevation in intracellular sodium or extra-cellular potassium, and pumps more sodium
out than it moves potassium in, so it is said to be electrogenic (12, 22, 52). Conversely,
the pump is inhibited by decreases in intracellular Na+ or extra-cellular K+. The exchange
of ions occurs as sodium attaches to the first intracellular loop of the molecule (12). In
the presence of potassium, this loop is hidden and instead a large cytoplasmic loop is
exposed (12). Both loops are involved in the exchange and make a conformational
change during activation (12). Denervation does not inhibit the activity of the Na+/K+
ATPase (14). This enzyme plays an important role in the maintenance of the
electrochemical gradients for Na+ and K+. It also contributes to the control of membrane
potential, thus contributing to the regulation of vascular tone and may be important in
vascular smooth muscle reactivity (11, 28, 35, 64). The Na+/K+ ATPase has been
proposed to contribute to vascular tone because inhibition of the enzyme results in
vasoconstriction in some systems (21, 55). As noted above, vasodilation as a result of
Na+/K+ ATPase activation through an increase in extra-cellular K+, has also lead to the
idea that this enzyme contributes to the regulation of vascular tone (11, 35).

Pharmacology
The Na+/K+ ATPase is inhibited by cardiac glycosides such as ouabain (12).
Ouabain has been used extensively as an indicator of activity of this enzyme. Ouabain, in
17

concentrations ranging from 10 µM to 1 mM, has been used to inhibit the activity of the
Na+/K+ ATPase (14, 19, 22, 35). Ouabain is found in mammals and is considered an
endogenous digitalis-like factor (12, 40). Ouabain is believed to act by inhibiting Na+/K+
ATPase pumping causing a more positively charged intracellular environment, which, in
turn, causes depolarization and vasoconstriction (12). The α subunit contains the ouabain
binding site (12). Ouabain binds to the pump when it is loaded with sodium (12). The H1
transmembrane segment has a high affinity for ouabain (12, 112), and the binding of
ouabain is stabilized by a conformational change of the molecule (12). The mechanism is
complex and little is understood about the binding site and process of inhibition.
Removal of K+ from the extra-cellular space or Na+ from the intracellular fluid
also inhibits the activity of the Na+/K+ ATPase. (14, 21, 22, 52). The pump is also
inactivated by reduced temperatures (28). Studies have shown that as temperatures
change from 26° to 36° C there is an increase in the pump activity (28).

Functional Hyperemia
Blood flow to resting skeletal muscle is quite low, approximately 3-5 ml 100 g
tissue-1 min-1 . During maximal activity blood flow can increase to 10-15 times this level .
Studies in isolated, perfused muscles demonstrated that this functional hyperemia, the
increased blood flow associated with muscle contraction, results from local factors
intrinsic to the muscle and its microcirculation. Despite intensive research over the past
40 years, the mechanisms responsible for functional hyperemia remain unclear probably
because there are a number of complimentary, overlapping and redundant processes
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involved in this response. To maintain focus the remainder of this section will
concentrate on the role played by elevated [K+]o in this process.
Early studies demonstrated that contracting skeletal muscle releases K+ and that
infusion of solutions with elevated K+ into resting muscle causes vasodilatation
supporting a role for K+ in functional hyperemia. Subsequent studies showed that
interstitial K+ is indeed increased during muscle contraction gracilis muscle exercise in
dogs, and this maximum concentration was reached quickly and slowly declined to a
steady state level (8). In dog gastrocnemius, the maximum potassium concentration
reached was 7.4 mM and also gradually decreased to a steady state (67). It was also
shown that the dilation associated with infusion of elevated K+ was transient and could be
involved with the initial phase of functional hyperemia, but not the sustained increase in
blood flow associated with maintained exercise (27).
It is not known if the transient nature of the response to elevated extracellular K+
observed in intact skeletal muscles reflects an intrinsic property of arteriolar smooth
muscle, or of the entire system. However, early studies of a number of preparations from
large vessels suggest that some vascular smooth muscle may relax in a transient fashion
to elevated K+ (55). In contrast recent studies of isolated small cerebral and coronary
arteries suggest that elevated K+ produces a sustained vasodilation in those vessels. (52)

Mechanism of Action of Elevated K +
The mechanism by which elevated K+ causes dilation of skeletal muscle arterioles
remains unclear. Studies in other systems showed that when extra-cellular K+
concentration is raised from 5 mM to 8-20 mM (dependent on the blood vessel studied),
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that the smooth muscle membrane potential hyperpolarized leading to vasodilation , a
finding supported by recent studies in small cerebral and coronary arteries (33, 34, 91,
104). In vitro studies of vessels from a variety of sources have implicated the Na+/K+
ATPase in this hyperpolarization and subsequent vasodilation for two reasons. First, the
hyperpolarization that is observed in many of these preparations is transient, consistent
with activation of the Na+/K+ ATPase, loss of intracellular Na+ and subsequent inhibition
of the pump (30). Second, in a number of cases the hyper-polarization or vascular smooth
muscle relaxation could be inhibited by ouabain (14, 19, 22, 35, 109). Consistent with
this hypothesis, Lombard and Stekiel have shown that a high concentration of ouabain (1
mM) inhibits K+-induced dilation of arterioles in rat cremaster muscle, in vivo. (99)
In contrast, studies by Edwards and Hirst in cerebral arterioles and recent studies
in small cerebral and coronary arteries have suggested that elevated K+ dilates these
vessels by activating KIR channels (33, 34, 84, 91, 104). It was shown that elevated K+
caused sustained hyperpolarization and dilation of these vessels that could be abolished
by a low concentration of Ba2+ (50 µM), and that this concentration of Ba2+ was selective
for KIR channels (33, 97, 125). In addition, Nelson’s group recently showed that there
was no K+-induced dilation of cerebral arteries in mice lacking the gene for Kir 2.1 (112).
Loeb and co-worker have suggested a similar mechanism in the in vivo response of
cremaster muscle arterioles to elevated K+ (97). However, these latter studies are difficult
to interpret because of changes in baseline diameter, data normalization and lack of
concentration-dependence in the responses that they recorded. Thus, the mechanism by
which elevated K+ dilates skeletal muscle arterioles remains to be established and forms
the central focus of this dissertation.
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CHAPTER 2

MATERIALS AND METHODS
Techniques
Animal Handling and Euthanasia
Male golden Syrian hamsters (80-150 g): Charles River Laboratories,
Wilmington, MA) were euthanised with sodium pentobarbital (>150 mg/kg body weight,
i.p.). The right testicle was exposed by scrotal incision and connective tissue surrounding
the cremaster muscle was carefully dissected away. The testicle was removed and placed
in a water-jacketed dissection bath maintained at 4° C, filled with calcium-free
physiological salt solution (PSS; 140 mM NaCl, 5 mM KCl, 1 mM MgCl2, 10 mM
HEPES, 10 mM glucose, 1.8 mM CaCl2 pH = 7.4), containing sodium nitroprusside (10
µM) and diltiazem (10 µM) to eliminate vasospasm during dissection.

Removal and Dissection of the Cremaster Muscle and Arterioles
The cremaster muscle was carefully separated from the testicle by cutting
away the connective tissue between them. An incision was made in the cremaster
to expose the serosal side of the muscle, allowing visualization of all of the blood
vessels. The muscle was spread out and pinned (#000 insect pins) on a silicon
(Sylgard 184) pad for further dissection. Either first or second order arterioles,
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devoid of smaller side branches, then were isolated by hand dissection. The
muscle layers surrounding the desired arteriole were dissected away, one layer at a
time, by cutting individual muscle fibers on either side of the vessel. This was
repeated until the desired length (1-2 mm) of arteriole was completely exposed.
The vessel segment was excised and transferred to the cannulation chamber using
a Wiretrol pipettor (50-100 µl) pretreated with albumin to reduce adhesion of the
isolated vessels to the glass barrel of the pipettor. Microdissections were
performed with the aid of a Wild Heerbrugg stereomicroscope (80X).

Cannulation
Cannulation was performed in a chamber filled with calcium-free PSS, kept at
room temperature. Arterioles were cannulated using glass micropipettes with tip outer
diameters of 40-50 µm, filled with PSS containing calcium (1.8 mM). Micropipettes were
formed from glass tubing (borosilicate capillary tubing, Warner Instruments) using a
pipette-puller and a microforge. The ends of the pipette were fire polished and bent at a
45° angle. Free ends of arterioles were gently pulled onto glass pipette tips and secured
with 11-0 nylon monofilament opthalmic suture (16-18 µm outside diameter), using
sharpened #5 Dumont forceps. The suture was prepared as loops prior to cannulation, so
that they would rest on the end of the pipette tip and easily slide over the cannulated
vessel and be easily tightened. Cannulation of arterioles was performed with the aid of a
Wild Heerbrugg stereomicroscope (40-80X magnification).
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Collecting and Recording Data
Arterioles were pressurized to 70 cm H2O and further exposed to a room
temperature flow of calcium-free PSS for ten minutes and the distance between the two
pipette tips adjusted to approximate the in vivo length of the arterioles. The cannulated
vessels were tested for leaks by closing the stopcock (Discofix 4-way) between the vessel
and the fluid column and monitoring diameter for several minutes. If a diameter change
was noted (indicating a leak in the vessel), the experiment was terminated and a new
vessel selected. If no leaks were detected, then the bath was slowly warmed to a
temperature of 34° C with a continuous flow of PSS containing calcium (1.8 mM CaCl2).
The solution flowed from a heated bath through heated tubing into the chamber. Heated
solution continually flowed in one end of the chamber and was aspirated from the other
end by suction.
Vessels were allowed to reach physiological temperature and equilibrate under
no-luminal flow conditions for 30-45 min. During this time the arterioles usually
developed tone, indicated by a reduction in diameter at constant pressure and a thickening
of the vessel walls. Once vessels developed tone, experimental protocols were performed
(see below). Cannulated vessels remained physiologically viable for at least 4-5 hours
under these conditions. All diameter changes were visualized and read continuously using
Diamtrak software, an automated diameter recording system. All data were graphically
recorded using a MacLab data acquisition system running Chart software. Figure 5
illustrates this experimental set up. At the end of each experiment, arterioles were
exposed to calcium-free PSS for at least 30 minutes to determine the maximum passive
diameter of each arteriole.
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To pressure
resevoir

Fig. 5- Cannulated Arteriole Set Up for Experimental Protocols.

Figure 5 shows the arteriole is cannulated and put in a chamber with continuous
flow and the diameter changes are visualized using Diamtrak and recorded by MacLab
data acquisition system.
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Experiment Protocols
Effects of a Calcium Channel Blocker: Diltiazem
The initial experiments looked at the vascular response to 10 µM diltiazem
(DTZM). Diltiazem causes vasodilation by blocking L-type calcium channels (4, 37, 76,
138,155). Elevated [K+]o has been proposed to cause vasodilation by membrane hyperpolarization and closing these channels (33, 63, 64). The presence and function
of these channels had to be established before any other experiments could be carried out
regarding a response to extra-cellular K+. Arterioles were exposed to PSS containing 10
µM DTZM for approximately five minutes. The DTZM was washed off with PSS and the
vessels were allowed to regain tone.

Does Elevated [K+] o Dilate Cannulated Cremasteric Arterioles?
To evaluate cannulated cremasteric arterioles as a model to study the mechanism
by which elevated [K+]o causes vasodilation in skeletal muscle, the effects of raising
[K+]o from 5 mM to 8.75 mM, 12.5 mM or 20 mM was assessed. This was accomplished
by measuring the diameter of arterioles bathed in PSS containing 5 mM K+ and then
rapidly switching to solutions containing, 8.75 mM, 12.5 mM or 20 mM while measuring
diameter for at least 10 minutes. The various K+ concentrations were applied in random
order, each followed by a 15-minute wash with normal PSS (5 mM K+). This procedure
was used to determine the stability of the K+ -induced dilations (transient or sustained).
At the end of this series, the vessels were washed for at least 30 minutes in PSS
containing calcium and allowed to regain tone.
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Does Dilation Induced by Elevated [K+] o Require a Functional Endothelium?
Endothelial cells can influence arteriolar tone by releasing vasoactive substances
such as NO and PGI2 (1, 42). Therefore, experiments were performed to determine if the
endothelium was involved in the response of cremasteric arterioles to elevated [K+]o. This
was done by comparing the dilation of arterioles when [K+]o was increased from 5 to 20
mM before and after removal of, or damage to, the endothelium. The vessels were
initially exposed to 20 mM K+ to determine the control response, followed by a 10
minute PSS wash and reestablishment of tone. Next, the vessels were exposed to
acetylcholine (Ach) (10 µM) very briefly to initiate a maximal dilatory response to this
agent, then washed for 10 minutes with PSS. Acetylcholine is known to elicit
vasodilation that is absolutely dependent on a functional endothelium (7, 11, 17, 49, 42)
and served as a functional test of the presence or absence of endothelial cells. A bubble of
air (approximately 0.5cc) then was allowed to perfuse through the vessel lumen. This was
accomplished by injecting a bolus of air into the line connected to the upstream pipette
and then opening the stopcock connected to the down stream pipette to allow flow
through the lumen of the arteriole. After the bubble had passed through the vessel, the
stopcock was closed and flow through the vessel stopped. The vessel then was allowed to
regain tone. If the vessels did not spontaneously regain tone, it was briefly exposed to 10
µM norepinephrine and then washed in PSS for at least 10 minutes. Once the arterioles
achieved a steady state of resting tone, they were re-exposed to 20 mM K+ and ACh to
determine their dilatory effects. If, however, tone was not reestablished, the experiment
was terminated.
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Does Ba2+ Inhibit Dilation Induced by Elevated [K+] o?
To test the hypothesis that KIR channels mediate K+ -induced dilation, arterioles
were exposed to 20 mM K+ in the absence or presence of the KIR channel blocker, BaCl2
(50 µM and 100 µM). The initial concentration of 50 µM was chosen because it has been
shown to abolish K+-induced dilation in cerebral and coronary arteries (119). The higher
concentration was employed because the 50 µM concentration did not produce consistent
abolition of the dilatory response in the present study. An initial control response was
determined using 20 mM K+ followed by a PSS wash. The arterioles were then exposed
to a pretreatment of barium in PSS containing 5 mM K+ at either of the concentrations for
10 minutes, directly followed by 20 mM K+ containing the same barium concentration.

Are KATP Channels Involved in Dilation Induced by Elevated [K+] o?
Barium ions have been reported to block KATP channels as well as KIR channels
(119). Therefore, to exclude the possibility that KATP channels were involved in the
response to elevated K+, the effects of KATP channel blocker glibenclamide (1 µM) were
assessed. The efficacy of glibenclamide was verified by assessing its effect on dilation
induced by cromakalim, a KATP channel agonist. An initial 20 mM K+ response was
determined, followed by a 10 minute wash in PSS. Next, the vessels were exposed to a
pretreatment of glibenclamide in PSS containing 5 mM K+ for 15 minutes, after which
time, the vessels were exposed to the antagonist in the presence of 20 mM K+. The
vessels were then washed for at least 10 minutes in PSS. Next, cromakalim was applied
for 10 minutes. This exposure was followed by a very long PSS wash, as this KATP
channel agonist was difficult to wash off. Finally, as a control, the vessels were
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prewashed again with glibenclamide for 15 min, this time followed by an exposure to
glibenclamide in the presence of cromakalim.

Are Effects of Ba2+ Selective?
The specificity of barium was also assessed by testing its effects on dilation
induced by acetylcholine (ACh) (5 µM). Acetylcholine is well known to elicit arteriolar
dilation associated with membrane hyperpolarization (7, 17, 121). An initial control
potassium response was determined by exposing the vessels to 20 mM K+. The vessels
were then washed with normal PSS for approximately 10 minutes, followed by exposure
to ACh (10 µM). The vessels were again washed with normal PSS for 10 minutes. A 10
minute prewash of 50 µM of Ba2+ was performed, directly followed by ACh in the
presence of Ba2+, for a duration of at least 5 minutes. The vessels were again washed with
PSS.

Does Ouabain Inhibit Dilation Induced by Elevated [K+] o?
In order to determine the role of the Na+/K+ ATPase, experiments were
conducted, using the same protocol used when determining the effects of BaCl2, in the
absence or presence of the Na+/K+ ATPase inhibitor, ouabain (0.1 mM and 1 mM). The
initial concentration of 0.1 mM was chosen because it has been used in other studies to
block Na+/K+ ATPase. (52, 65, 81, 98) A higher concentration was employed because
consistent abolition of the dilation, as a result of Na+/K+ ATPase block, was not seen in
this skeletal muscle arteriole model, and it has been used in other studies of skeletal
muscle microcirculation (14, 35, 52).
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Are Effects of Ouabain Specific?
In an effort to insure that the ouabain block was specific, acetylcholine (ACh) (5
µM) was used in place of the potassium, as a vasodilator. An initial control potassium
response was determined by exposing the vessel to 20 mM K+. The vessels were then
washed with PSS for approximately 10 minutes, followed by exposure to ACh. The
vessels were again washed with PSS for 10 minutes. This was followed by ACh in the
presence of ouabain, for a duration of at least 5 minutes. The vessels were again washed
with PSS. The ten minute prewash of 0.1 mM of ouabain was not performed because
recovery from ouabain exposure was not reliable. To ensure that all aspects of the
experiment could be accomplished, the number of ouabain exposures, per protocol was
limited.

Does a Combination of Ba2+ & Ouabain Abolish Dilation Induced by
Elevated [K+] o
The previous experiments implicated both KIR channels and the Na+/K+ ATPase
in K+ -induced dilation. An initial control response was determined using 20 mM K+
followed by a PSS wash. The vessels were allowed to regain tone. Then, to determine if
both mechanisms contribute to K+ -induced dilation, a cocktail of barium and ouabain,
with the optimal concentrations, 100 µM and 1 mM respectively, were used in an effort
to totally inhibit the response. Arterioles were exposed to 20 mM K+ in the absence or
presence of the cocktail of barium and ouabain.
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Statistics
Summary data are presented as means ± SE. Data were analyzed using t tests and
ANOVA (single factor, two factor without replication or factorial) followed by a StudentNewman-Keuls test to compare mean values, if appropriate. Differences were considered
to be of statistical significance if P < 0.05.
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CHAPTER 3

RESULTS
Arteriole Responses
First and second order arterioles were isolated from hamster cremaster muscles. A
total of 81 viable vessels were studied. Their average maximal diameter was 107 ± 2 µm
and their average diameter with tone was 59 ± 1 µm.

Effects of Diltiazem
These initial experiments were designed to determine the presence and
activity of L-type calcium channels. Exposure of cremasteric arterioles to 10 µM
diltiazem caused dilation (Fig. 6). Arterioles exposed to calcium-free PSS also
dilated (Fig. 6). Both diltiazem and calcium-free PSS caused similar maximal
dilation. Arterioles with a resting diameter (tone) of 71 ± 5 µm dilated to a
diameter of 105 ± 7 µm in the presence of diltiazem and to 113 ± 6 µm in the
presence of calcium-free PSS, both being significantly different from the control
diameter (n = 6, P < 0.05), but not significantly different from one another (P >
0.05).
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Fig. 6-Diltiazem and Arteriolar Dilation

Figure 6 provides an analysis of variance corrected for repeated measures
indicated a significant effect of DTZM and Ca2+ free PSS on diameter. * = significantly
different from control diameter (at 0 µM DTZM and 1.8 mM Ca2+), P < 0.05, but not
significantly different from each other, P > 0.05.
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Elevated [K+]o Results in Dilation of Cannulated Cremasteric Arterioles
Elevation of bath potassium concentration from 5 mM to 8.75 mM, 12.5 mM or
20 mM resulted in concentration-dependent arteriolar dilation from a resting diameter of
66 ± 6 µm to 72 ± 4 µm (P > 0.05), 81 ± 5 µm (P < 0.05), and 85 ± 5 µm (P < 0.05)
respectively (n = 8, Fig. 7). Six out of eight times, the peak diameter occurred in the
presence of 20 mM K+. Dilations at all concentrations were transient as seen Figure 7.
Peak potassium-dilation, in nearly all of the 75 control cases, was reached in less
than two minutes and the vessels returned to, or below resting diameter after 7.5 minutes
of K+ exposure.
There appeared to be a weak, negative correlation between the dilation induced by 20
mM K+ (relative to the maximum possible dilation) and the maximum diameter of the
arterioles studied (r = -0.34, n = 75, P < 0.05). That is, larger vessels tended to dilate less
than smaller vessels.

Dilation Induced by Elevated [K+]o does not Require a Functional Endothelium
Endothelial cells release a number of vasodilator substances in response to agonist and
physical stimulation that strongly impact the contractile activity of the overlying smooth
muscle cells (1). The role played by endothelial cells in the response of skeletal muscle
arterioles to elevated extracellular potassium is not known. Therefore, the effects of
removal of endothelial cells on K+-induced dilation of cremasteric arterioles were
examined. Perfusion of cannulated arterioles with an air bubble to remove the
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Fig. 7- Concentration-dependent Potassium Dilation

Figure 7 top panel digitized diameter demonstrates the transient and
concentration-dependent nature of K+-induced dilation in isolated hamster cremasteric
arterioles. Bottom panel: Peak arteriolar diameters (mean ± SE, n = 8) in response to the
K+ concentrations indicated. Analysis of variance corrected for repeated measures.
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endothelium caused no significant change in resting diameter (control diameter = 54 ± 3
µm; diameter after air bubble perfusion = 61 ± 2 µm, n=5; P > 0.05). However,
acetylcholine-induced dilation of the arterioles, which depends on a functional
endothelium (7, 11, 17, 39), was abolished. (Fig 8). These data verify that air bubble
perfusion eliminated endothelium-dependent dilation of cremasteric arterioles. Despite
the loss of endothelium-dependent reactivity, the arterioles continued to respond to
elevated [K+]0. (Fig. 9), and attained the same peak diameter as prior to air bubble
perfusion.
Removal of the arteriolar endothelial lining was important in determining its role
in the K+-induced dilation, but perfusion of the vessels with an air bubble proved to be a
somewhat difficult technique. Although much care was taken, it was often difficult to
control the speed at which bubbles passed through the arteriole lumen. If a large bubble
moved through a vessel too quickly, there appeared to be significant damage to the
vessel. The damage may have been across the full length or partial length of the arteriole;
the vessels appeared dilated and there was no recovery even after long washes with PSS.
The damaged vessels also would not respond to vasoactive substances.
The passage of small, slower air bubbles proved to be most the effective in the
removal of the endothelium while maintaining the integrity of the smooth muscles. These
vessels recovered after a PSS wash and were responsive.
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Fig. 8- Removal of Endothelium

Figure 8 shows peak arteriolar diameters (mean ± SE, n = 5). Control
diameters represent resting diameters in the presence and absence of endothelium.
Acetylcholine diameters represent the peak diameters in response to 10 µM
acetylcholine, both in the presence and absence of endothelium. Factorial ANOVA
indicated significant acetylcholine effects with endothelium present, P < 0.05, but
there was no significant acetylcholine effect with endothelium absent. * =
significantly different from control diameter.
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Fig. 9- Uninhibited K+ Induced Dilation

Figure 9 shows peak arteriolar diameters (mean ± SE, n = 5). Control
diameters represent resting diameters in the presence and absence of endothelium.
KCl diameters represent peak diameters during exposure to 20 mM KCl in the
presence and absence of endothelium. Factorial ANOVA indicated significant KCl
effects both in the presence and absence of endothelium. * = significantly different
from control diameter, P < 0.05.
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Role of KIR Channels
Studies in other blood vessels have implicated KIR channels in K+-induced
dilation (33-35, 84, 91, 97, 118, 119). However, the role played by these channels in K+induced dilation of skeletal muscle arterioles remains unclear. Therefore, we examine the
effects of Ba2+, a known KIR channel blocker (118-120) on dilation of cremasteric
arterioles to elevated [K+]o. We found that exposure of cannulated arterioles to Ba2+ (50
or 100 µM) caused significant constriction (Fig. 10) and inhibition of the peak dilation
induced by raising [K+]o from 5 to 20 mM (Fig. 10). Although 100 µM Ba2+ tended to
cause a slightly greater increase in tone, the degree of inhibition of the K+-induced
dilation was not significantly different for the two concentrations of Ba2+ tested: 50 µM
Ba2+ caused 48 ± 14% inhibition and 100 µM Ba2+ caused 41 ± 16% inhibition of 20 mM
K+-induced dilation (P > 0.05). These data suggest that their effects were near maximal.
Dilation was abolished in only one experiment at each of the two Ba2+ concentrations
tested.

Role of K ATP Channels
In the previous section barium was used to assess the role played by KIR channels
in potassium-induced vasodilation. However, barium has also been demonstrated to block
currents through KATP channels (118-120, 125). Therefore, the effects of glibenclamide (1
µM), a selective KATP channel inhibitor, on potassium induced dilation were examined.
Superfusion of cannulated cremasteric arterioles with 1 µM glibenclamide had no
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Fig. 10- Effects of Barium on Potassium-induced Dilation

The top panel of Figure 10 shows partial inhibition of K+-induced dilation by
Barium (50 µM). Bottom panel: Peak arteriolar diameters (mean ± SE, n = 8 for both
concentrations). Control diameters represent diameters before and after exposure to K+ in
the absence of barium and with barium pre-wash, respectively. 5 mM K+ diameters
represent resting diameters prior to 20 mM K+ exposure. 20 mM K+ diameters represent
the peak diameter during exposure to 20 mM K+, both in the absence and presence of 50
or 100 µM barium. Factorial ANOVA indicated significant K+ and barium effects. + =
significantly different from diameter in 5 mM K+ in the same group, * = significantly
different from control diameter, same K+ concentration, ∆ = significantly different from 5
mM K+ same group and different from control 20 mM K+ diameter, P < 0.05.
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significant effect on resting diameter and did not inhibit dilation of arterioles when
extracellular potassium concentration was elevated from 5 to 20 mM (Fig. 11). The
efficacy of KATP channel block by glibenclamide was verified using the KATP channel
agonist, cromakalim. As seen in Fig. 12, 1 µM glibenclamide eliminated arteriolar
dilation induced by 10 µM cromakalim. Thus, 1 µM glibenclamide effectively inhibited
KATP channels in cremasteric arterioles but had no effect on K+-induced dilation.

Determination of Selectivity of Barium Inhibition for KIR
As a control for selectivity, the effects of barium on acetylcholine-induced
dilation were determined. The magnitudes of arteriolar dilation due to increased
potassium or exposure to 5 µM acetylcholine are similar (Fig. 13). As previously shown,
Ba2+ (50 µM) inhibited potassium-induced dilation (Fig. 13). However, dilation induced
by 5 µM acetylcholine was unaffected (Fig. 13). These data suggest that the effects of
Ba+ are selective for K+-induced dilation.

Role of Na +/K + ATPase
The Na+/K+ ATPase has also been proposed to mediate K+-induced vasodilation (12, 22,
52). However, the role played by this transporter in skeletal muscle arterioles has not
been firmly established. Therefore, the effects of ouabain, an inhibitor of the pump, on
dilation of cremasteric arterioles in response to elevation of [K+]o from 5 to 20 mM
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Fig. 11- K+ Induced Dilation Uninhibited by Glibenclamide

Figure 11 shows peak arteriolar diameters (mean ± SE, n = 6). Control
diameters represent resting diameters prior to Glibenclamide (1 µM) exposure and
prior to KCl (20 mM) exposure. KCl diameters represent the peak diameter during
exposure to KCl, both in the absence and presence of Glibenclamide. Factorial
ANOVA indicated significant KCl effects in the absence and presence of
Glibenclamide. * = significantly different from control diameter, P < 0.05.
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Fig. 12- Cromakalim-induced Dilation Inhibited by Glibenclamide

Figure 12 shows peak arteriolar diameters (mean ± SE, n = 6). Control
diameters represent resting diameters prior to glibenclamide (1 µM) exposure and
prior to cromakalim (2 µM) exposure. cromakalim diameters represent the peak
diameter during exposure to cromakalim, both in the absence and presence of
glibenclamide. Factorial ANOVA indicated significant glibenclamide effects, * =
significantly different from control diameter, P < 0.05.
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Fig. 13- Acetylcholine-induced Dilation Uninhibited by Barium

Figure 13 shows peak arteriolar diameters (mean ± SE, n = 4). Control diameters
represent resting diameters in the absence of Ba2+ (50 µM) and peak diameters seen with
indicated vasodilators (5 µM Acetylcholine, 20 mM KCl), in the absence of Ba2+. Barium
diameters represent diameters in the absence and presence of indicated dilators. Factorial
ANOVA indicated significant acetylcholine and KCl response in the absence of Ba2+, P <
0.05. Significant acetylcholine response in the presence of Ba2+ was also indicated, P <
0.05. * = significantly different than control with no vasodilator. ∆ = significantly
different than control with Ba2+ present.
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were assessed. As shown in Figure 14, superfusion of arterioles either concentration of
ouabain (0.1 or 1.0 mM) had no effect on the diameter of arterioles in 5 mM K+.
However, both concentrations of this cardiac glycoside (0.1 and 1.0 mM) significantly
inhibited K+-induced dilation in a concentration-dependent manner: the mean dilations
that remained were not significantly different from zero for either concentration of
ouabain. At the 0.1 mM concentration, ouabain abolished dilator responses to elevated
[K+]o in 4 out of 9 experiments (44%) and inhibited by 91% in one additional experiment
(mean %inhibition = 73 ± 15 %). In the remaining 4 experiments, dilation was inhibited
by less than 58%. With 1 mM ouabain, dilation was eliminated in 7 of 14 experiments
(50%) and severely inhibited by 75 to 93% in three other experiments (mean %inhibition
= 80 ± 11 %). In the remaining four trials, dilation was inhibited by less than 54%.

Ouabain Effects on Acetylcholine-induced Dilation
As a control for selectivity, the effects of ouabain on acetylcholine–induced
dilation were examined. As shown previously, dilation induced by 5 µM acetylcholine
caused dilation similar to that observed when [K+]o was elevated from 5 to 20 mM (Fig.
15) and ouabain (0.1 mM) inhibited K+-induced dilation (Fig. 15). However, this
concentration of ouabain had no significant effect on dilation induced by 5 µM
acetylcholine (Fig. 15). These data suggest that this concentration of ouabain selectively
inhibited K+-induced dilation.
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Fig. 14- Ouabain and Potassium-induced Dilation

The top panel of Figure 14 records partial inhibition of K+-induced dilation by
ouabain (1 mM). Bottom panel: Peak arteriolar diameters (mean ± SE, n = 9 at 0.1 mM, n
= 14 at 1 mM). 5 mM K+ diameters represent resting diameters prior to 20 mM K+
exposure. 20 mM K+ diameters represent the peak diameter during exposure to 20 mM
K+, both in the absence and presence of 0.1 or 1 mM ouabain. + = significantly different
from diameter in 5 mM K+ in the same group, * = significantly different from control
diameter, same K+ concentration, ∆ = significantly different from 5 mM K+ same group
and different from control 20 mM K+ diameter, P < 0.05.
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Fig. 15- Ouabain and Acetylcholine-induced Dilation

Figure 15 shows peak arteriolar diameters (mean ± SE, n = 4). Control
diameters represent resting diameters without any vasodilator present and peak
diameters seen with indicated dilators (5 µM Acetylcholine, 20 mM KCl), in the
absence of Ouabain (0.1 mM) Ouabain diameters represent diameters in the
absence and presence of indicated dilators. Factorial ANOVA indicated significant
Acetylcholine and KCl response in the absence of Ouabain, P < 0.05. Significant
Acetylcholine response in the presence of Ouabain was also indicated, P < 0.05. *
= significantly different than control with no vasodilator. ∆ = significantly
different than control with Ouabain present.
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Ouabain – Barium Cocktail Abolishes K+ -induced Dilation
Neither Ba+2 nor ouabain consistently eliminated K+-induced dilation. Therefore,
the effects of the combination of these two inhibitors were assessed. Superfusion of
cremasteric arterioles with both Ba2+ (100 µM) and ouabain (1 mM) caused arteriolar
constriction and consistent inhibition of dilation induced by elevation of [K+]o from 5 to
20 mM (Fig. 16). In all seven experiments, this inhibitor combination inhibited dilation
by more than 91% (mean % inhibition = 95 ± 1.5%).

47

diameter (µm)

120

20 mM K+

20 mM K+

100 µM BaCl2 + 1 mM ouabain

100
80
60
40

100

2 min
5 mM K+

20 mM K+
+

diameter (µm)

80
60

∆

*

40
20
0
100 µM barium +
1 mM ouabain

control

Fig. 16- Barium – Ouabain Cocktail

Top panel of Figure 16 shows an abolition of K+-induced dilation by the
combination of Ba2+ (100 µM) and ouabain (1 mM). Bottom panel shows peak arteriolar
diameters (mean ± SE, n = 7). 5 mM K+ diameters represent resting diameters prior to 20
mM K+ exposure. 20 mM K+ diameters represent the peak diameter during exposure to
20 mM K+, both in the absence and presence of the combination of Ba2+ (100 µM) and
ouabain (1 mM). + = significantly different from diameter in 5 mM K+ in the same group,
* = significantly different from control diameter, the same K+ concentration, ∆ =
significantly different from 5 mM K+ same group and different from control, 20 mM K+
diameter, P < 0.05.
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CHAPTER 4

DISCUSSION

The purpose of the present investigation was to evaluate the mechanism by which
elevated [K+]o causes dilation of skeletal muscle arterioles. This was accomplished by
studying the responses of isolated, cannulated, pressurized segments of hamster
cremasteric arterioles. As studies in the literature suggested that KIR channels (18, 33, 34,
84, 85, 97) or the Na+/K+ ATPase (9, 12, 40, 46, 52, 55, 65, 100) were likely potential
mechanisms, the focus was on these two pathways. The results reported in this study
suggest that both mechanisms may contribute to the means by which elevated [K+]o
causes arteriolar dilation.
Elevated [K+]o caused concentration-dependent dilation, with maximal effects
observed at a concentration of 20 mM. These findings are similar to recent results
reported in other systems (14, 30, 53, 94, 97, 104, 115). However, in contrast to findings
in small cerebral and coronary arteries, K+-induced dilation of cremasteric arterioles was
transient (111, 112, 119). These data are consistent with in vivo studies of hamster
cremasteric arterioles (30) and indicate that the transient nature of the response to
elevated [K+]o is an intrinsic property of skeletal muscle arterioles. These findings
support the hypothesis that elevated [K+]o can contribute to the initiation of functional
hyperemia in skeletal muscle, but that it is not responsible for the maintained phase of
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vasodilation that is associated with prolonged exercise (8, 27, 67).
There is cellular communication between vascular smooth muscle and
endothelium (52). Endothelial cells have been shown to respond to different stimuli, and
to cause relaxation of smooth muscle by releasing vasodilating factors such as
prostacyclin and nitric oxide (1, 42, 52). In addition, endothelial cells may be electrically
coupled to smooth muscle cells by myoendothelial gap junctions (52). Therefore, we
assessed the role played by the endothelium in the dilatory response to elevated [K+]o.
Removal of the endothelium by air-bubble perfusion, verified by loss of reactivity to
acetylcholine, did not eliminate K+-induced dilation in the present study. These data
indicate that K+-induced dilation of skeletal muscle arterioles does not require the
presence of a functional endothelium and are consistent with observations in other
systems (84). The possibility that a functional endothelium may contribute to, or
modulate the arteriolar response to elevated [K+]o cannot be excluded. However, these
data indicate that arteriolar muscle cells can respond independently to this stimulus.
Elevated [K+]o appears to relax vascular smooth muscle by hyperpolarizing the
membrane of these cells (33, 34, 52, 55, 84, 91, 104]. This hyperpolarization then closes
voltage-gated Ca2+ channels, decreasing the influx of activator Ca2+ and resulting in
relaxation of the smooth muscle and vasodilatation (76). During this study, membrane
potential was not measured. However, the presence of functioning L-type calcium
channels that contribute to arteriolar tone was determined. Arterioles dilated near
maximally when exposed to the L-type Ca2+ channel blocker, diltiazem. These data are
consistent with numerous in vitro studies (4, 37, 76) and indicate that Ca2+ influx through
L-type Ca2+ channels contribute substantially to arteriolar tone. These data also suggest
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that hyperpolarization would be a viable mechanism by which to dilate these arterioles.
Edwards and Hirst first proposed that Kir channels were involved in K+-induced
dilation in cerebral arterioles (33). This idea was later illustrated by Nelson and
colleagues (112) who have provided compelling evidence that Kir channels mediate K+induced dilation of small cerebral and coronary arteries (33, 34, 84, 91, 104). In those
studies, they showed that low micromolar concentrations of Ba2+ could abolish the
hyperpolarization and vasodilation induced by elevated [K+]o. In contrast, this study
shows that Ba2+ concentrations up to 100 µM only attenuated K+-induced dilation. It does
not appear that the low of efficacy of Ba2+ in the present study resulted from the use of
submaximal concentrations of this Kir channel blocker, because the degree of inhibition
observed was similar with both 50 and 100 µM concentrations.
Barium ions have been shown to block KATP channels as well as KIR channels
(112, 120). To eliminate the possibility that KATP channels were involved in K+-induced
dilation, the effects of glibenclamide, a KATP channel blocker, on the response to elevated
[K+]o were assessed. Glibenclamide (1 µM) eliminated vasodilation to the KATP channel
agonist, cromakalim (10 µM). However, glibenclamide did not inhibit K+-induced
dilation of cremasteric arterioles. These data indicate that KATP channels are not involved
in the arteriolar response to elevated [K+]o in this tissue.
Exposure of cremasteric arterioles to Ba2+ caused a sustained increase in tone.
Non-specific effects due to this constriction cannot be completely ruled out. However,
dilation induced by acetylcholine was not inhibited by Ba2+ suggesting that the effects of
the blocker were not totally non-specific. Therefore, we conclude that Kir channels may
contribute to a portion of the response to elevated [K+]o.
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Early studies of the mechanism by which elevated [K+]o causes vasodilation in
skeletal muscle proposed that the Na+/K+ ATPase may be involved (55, 71, 82, 133, 140).
More recently, Lombard and colleagues supported this hypothesis by showing that
ouabain (1 mM) inhibits K+-induced dilation of cremasteric arterioles in vivo. The
findings in this study corroborate their conclusions. Ouabain (0.1 and 1.0 mM)
substantially inhibited K+-induced dilation of cremaster arterioles in vitro. Furthermore,
this effect appeared to be specific because acetylcholine-induced dilation was not altered.
These data also support a role for the Na+/K+ ATPase in K+-induced dilation of skeletal
muscle arterioles.
While ouabain was quite effective in dampening K+-induced dilation, substantial
dilation remained in a number of experiments even in the presence of a high
concentration of this Na+/K+ ATPase inhibitor (1 mM ouabain). This observation,
coupled with these findings with Ba2+, suggested that both Kir channels and the Na+/K+
ATPase may mediate K+-induced dilation in skeletal muscle arterioles. Therefore, the
effects of the combination of Ba2+ (0.1 mM) and ouabain (1 mM) were examined. This
cocktail of inhibitors consistently produced greater than 91% inhibition of K+-induced
dilation in isolated cremasteric arterioles. These observations support the hypothesis that
both Kir channels and the Na+/K+ ATPase are involved in the mechanism of action of
elevated [K+]o.
As was observed with Ba2+ alone, treatment of arterioles with both Ba2+ and
ouabain caused arteriolar constriction. Furthermore, control experiments to assess the
specificity of the combination of inhibitors were not performed as they were with Ba2+
and ouabain alone. Thus, the possiblility of non-specific effects of the inhibitor cocktail
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cannot be completely dismissed. Future experiments should address this issue.
The data collected in this study support the hypothesis that K+-induced dilation of
cremasteric arterioles involves activation of both KIR channels and the Na+/K+ ATPase.
Similar conclusions have been drawn in rat cerebral and renal arteries (33, 44, 84, 91,
100, 104, 115, 119 ). These studies may also resolve the conflict between the findings of
Lombard and Stekiel (99) supporting a role for the Na+/K+ ATPase in rat cremasteric
arterioles, and Loeb et al. (97) who suggest that KIR channels are involved in the same
tissues. In both studies, inhibition of K+-induced dilation by ouabain (Lombard and
Stekiel (99)) or Ba2+ (Loeb, et al. (97)) was only partial. Thus, dual mechanisms, as we
propose in the present study, may have been involved.
As noted above, K+-induced dilations were consistently transient in all vessels
studied and for all concentrations of K+ that were tested. The mechanism responsible for
the lack of a sustained response is not clear. Activation of the Na+/K+ ATPase by elevated
[K+]o should be transient and should cause as transitory hyperpolarization as Na+ is
pumped out of the cells and intracellular [Na+] decreases (12, 22, 52). This is consistent
with the transient dilation that is observed. However, in contrast, activation of KIR
channels should lead to a sustained hyperpolarization and hence dilation as has been
reported by others (112). Thus, if both mechanisms are involved one would predict that
inhibition of the pump by ouabain should lead to a more sustained response. However,
this was not observed. In the presence of ouabain, what responses remained also were
transient (see RESULTS). It is possible that hyperpolarization activates depolarizing
currents that overwhelm any hyperpolarization caused by small outward currents through
KIR channels such that maintained hyperpolarization (dilation) is prevented.
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Electrophysiological studies will be required to resolve this dilemma and to determine
exactly why K+-induced dilations are transient in skeletal muscle arterioles.
This study showed that in cremasteric arterioles, K+-induced dilation likely results
from two mechanisms: activation of Kir channels and the Na+/K+ ATPase. These
mechanisms have been shown to result in potassium induced dilations seen in cerebral,
coronary and renal arteries (33, 34, 44, 84, 91, 100, 104, 115, 119, 125). However, these
studies show only partial inhibition of the dilation as a result of applying blockers for
only one mechanism. This study shows that applying blockers for both mechanisms
simultaneously resulted in abolition of potassium induced dilation. It appears that
initiation of this dilation is dependent upon the Na+/K+ ATPase, while KIR channels may
modulate dilation seen during activity. These data in correlation with single cell patch
clamp data may provide a more clear responsibility of each mechanism during potassium
induced arteriolar dilation.
Finally, it was observed that large arterioles tended to dilate less (relative to their
maximal diameters) than did small arterioles. This may indicate that there are significant
functional differences in different size arterioles. The density of Kir channels has been
reported to increase as vessel diameter decreases in the coronary vasculature (118). Such
a change might contribute to the apparent differences in reactivity to [K+]o observed in
the present study. Further research will be required to settle this issue.
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